Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity. (26th August 2022)
- Record Type:
- Journal Article
- Title:
- Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity. (26th August 2022)
- Main Title:
- Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity
- Authors:
- Singh, Aakriti
Yadagiri, Ganesh
Javaid, Aaqib
Sharma, Krishna Kumar
Verma, Anurag
Singh, Om Prakash
Sundar, Shyam
Mudavath, Shyam Lal - Abstract:
- Abstract : VBS-AmB-SLN as a stable oral anti-leishmanial carrier. Abstract : Surface-functionalized vitamin B12 (VB12 ) biocompatible nanoparticles exploit the well-characterized uptake pathway of VB12, shielding it from enzymatic degradation and inadequate absorption. In this perspective, subsequent to escalated mucus interaction and diffusion analysis, the nanoparticles were investigated by immunostaining with the anti-CD320 antibody, and their internalization mechanisms were examined by selectively blocking specific uptake processes. It was observed that their internalization occurred via an energy-dependent clathrin-mediated mechanism, simultaneously highlighting their remarkable ability to bypass the P-glycoprotein efflux. In particular, the synthesized nanoparticles were evaluated for their cytocompatibility by analyzing cellular proliferation, membrane viscoelasticity, and fluidity by fluorescence recovery after photobleaching and oxidative-stress detection, making them well-suited for successful translation to a clinical setup. Our previous in vitro antileishmanial results were paramount for their further in vivo and toxicity analysis, demonstrating their targeted therapeutic efficiency. The augmented surface hydrophilicity, which is attributed to VB12, and monomerization of amphotericin B in the lipid core strengthened the oral bioavailability and stability of the nanoparticles, as evidenced by the fluorescence resonance energy transfer analysis.
- Is Part Of:
- Biomaterials science. Volume 10:Number 19(2022)
- Journal:
- Biomaterials science
- Issue:
- Volume 10:Number 19(2022)
- Issue Display:
- Volume 10, Issue 19 (2022)
- Year:
- 2022
- Volume:
- 10
- Issue:
- 19
- Issue Sort Value:
- 2022-0010-0019-0000
- Page Start:
- 5669
- Page End:
- 5688
- Publication Date:
- 2022-08-26
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/bm ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d2bm00979j ↗
- Languages:
- English
- ISSNs:
- 2047-4830
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.724000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23874.xml